# Incyte Corporation

Canonical: https://abierto.us/vendors/incyte-corporation-ztm9u2g5vtk8

- UEI: ZTM9U2G5VTK8
- CAGE: 1F8A9
- Location: Wilmington, DE
- Awards in window: 8 (32 transactions), $134,018 obligated, January 12, 2024 to September 2, 2026

## Awarding agencies

- Department of Veterans Affairs: 8 awards, $134,018

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: $134,018

## Competition

- Full and Open Competition: 8 awards

## Largest awards

- 36C26124N0749 (delivery order): $119,619, 261-Network Contract Office 21. Pemigatinib. https://www.usaspending.gov/award/CONT_AWD_36C26124N0749_3600_36F79720D0189_3600/
- 36C26124N0381 (delivery order): $13,291, 261-Network Contract Office 21. Pemigatinib. https://www.usaspending.gov/award/CONT_AWD_36C26124N0381_3600_36F79720D0189_3600/
- 36C26124N0408 (delivery order): $13,291, 261-Network Contract Office 21. Pemigatinib Pemazyre. https://www.usaspending.gov/award/CONT_AWD_36C26124N0408_3600_36F79720D0189_3600/
- 36C26124N0511 (delivery order): $13,291, 261-Network Contract Office 21. Pharmacy Order. https://www.usaspending.gov/award/CONT_AWD_36C26124N0511_3600_36F79720D0189_3600/
- 36E79721A0005: $0, Nac Pharmaceuticals. Exercise Option Year 4. https://www.usaspending.gov/award/CONT_IDV_36E79721A0005_3600/
- 36E79726A0008: $0, Nac Pharmaceuticals. BPA for Pemazyre. https://www.usaspending.gov/award/CONT_IDV_36E79726A0008_3600/
- 36F79720D0189: $0, Nac Federal Supply Schedule. Lifecycle Change - Temporary to Permanent. https://www.usaspending.gov/award/CONT_IDV_36F79720D0189_3600/
- 36C26023F0231 (delivery order): -$25,474, 260-Network Contract Office 20. Pemigatinib 13.5MG Tablet. https://www.usaspending.gov/award/CONT_AWD_36C26023F0231_3600_36F79720D0189_3600/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/incyte-corporation-ztm9u2g5vtk8.